Personalized Medicine Through Big Data Analytics
with Colin Hill, CEO, president, chairman
Monday, April 23, 2012
10–11:30 a.m.
Biodesign Institute Auditorium
ASU Tempe campus
Download the seminar flier
Speaker Biosketch
Founded in 2000, Gene Network Sciences (GNS) Healthcare, a Via Science Company, is a healthcare analytics company focused on advancing and applying industrial-scale data analytics to empower key healthcare stakeholders to solve complex care, treatment and cost challenges. GNS is a multi-disciplinary group of physicists, actuaries, geneticists, engineers, business experts and computer scientists, passionate about building knowledge data to improve healthcare.
Colin Hill brings years of hands-on scientific experience to his role, with expertise in the areas of computational physics and systems biology. Colin is a frequent speaker at international scientific and industry conferences and has appeared in numerous publications and television segments including The Wall Street Journal, CNBC Morning Call, Nature, Forbes, Wired and The Economist. He serves as CEO and Chairman of GNS Healthcare’s parent company Via Science, and chairman of the board of Fina Technologies, a subsidiary of Via Science that applies next-generation artificial intelligence technologies to real-time financial trading. He also serves on the board of directors of AesRx, a biopharmaceutical company dedicated to the development of a new treatment for sickle cell disease.
In 2004, Colin was named to MIT Technology Review’s TR100 list of the top innovators in the world under the age of 35. He graduated from Virginia Tech with a degree in physics and earned master’s degrees in physics from McGill University and Cornell University.
